• If you are wondering whether National Health Investors is priced fairly after its recent run, or if the current share price offers value, this article focuses squarely on what you are getting for the price you pay.
• The stock recently closed at US$87.68, with a 1 year return of 29.2% and a 3 year return of 93.1%, alongside a 30 day return of 10.7% and a 7 day return showing a 1.2% decline.
• Recent attention on the senior housing and healthcare real estate space has kept National Health Investors on many investors' watchlists, as funding conditions and sector sentiment continue to be key talking points. Broader discussions around healthcare spending and long term care needs have also framed how investors think about the reliability of rent streams for landlords like NHI.
• On our checks, National Health Investors records a valuation score of 4 out of 6, which sets up an interesting comparison between different valuation methods. We will also look at a less conventional way to think about value by the end of this article.

Approach 1: National Health Investors Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a business could be worth today by projecting its future adjusted funds from operations and then discounting those cash flows back into today’s dollars.

For National Health Investors, the model uses last twelve month free cash flow of about $200.6 million as a starting point. Analyst based projections and extrapolations by Simply Wall St map out cash flows over the next decade, with free cash flow for 2030 projected at $390.9 million. These ten year projections follow a two stage free cash flow to equity framework that is tailored to real estate style cash generation.

When all those projected cash flows are discounted back and summed, the model arrives at an estimated intrinsic value of $198.86 per share. Compared with the recent share price of $87.68, the DCF output suggests the shares trade at a 55.9% discount to this estimate, which indicates the stock may be undervalued using this method.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests National Health Investors is undervalued by 55.9%. Track this in your watchlist or portfolio, or discover 54 more high quality undervalued stocks.

Approach 2: National Health Investors Price vs Earnings

For a profitable business like National Health Investors, the P/E ratio is a common way to gauge what you are paying for each dollar of earnings. Investors usually accept a higher P/E when they expect stronger earnings growth or see the company as lower risk, while slower growth or higher risk tend to justify a lower, more cautious P/E.

National Health Investors currently trades on a P/E of 28.4x, compared with the Health Care REITs industry average of about 26.0x and a peer group average of 66.0x. Simply Wall St also provides a Fair Ratio of 35.1x, which reflects the P/E that could be expected given factors such as the company’s earnings profile, industry, profit margins, market size and risk characteristics.

This Fair Ratio is designed to be more tailored than a simple comparison with peers or the broad industry, because it attempts to adjust for differences in growth potential, risk and profitability rather than assuming all companies deserve the same multiple. With the current P/E of 28.4x sitting below the Fair Ratio of 35.1x, the shares appear undervalued on this metric.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your National Health Investors Narrative

Earlier we mentioned that there is an even better way to understand valuation. Let us introduce you to Narratives, a simple framework on Simply Wall St’s Community page. You connect your view of National Health Investors’ story to a set of forecast assumptions and a Fair Value, then compare that Fair Value with today’s price to decide whether the stock looks attractive or stretched. The Narrative itself keeps updating as new earnings or news arrive. One investor might build a more optimistic NHI Narrative that leans on assumptions like revenue growth of 10.61%, a 42.87% profit margin and a future P/E of 25.54x, to support a Fair Value closer to the recently updated US$85.63. Another might plug in more cautious assumptions around occupancy, tenant concentration and funding risks, to arrive at a lower Fair Value and a very different conclusion about what to do next.

Do you think there's more to the story for National Health Investors? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.